TY - EJOU
AU - Moon, Hyun-Jung
AU - Park, 1
So-Young
AU - Lee, 1
Su-Hoon
AU - Kang, Chi-Dug
AU - Kim, Sun-Hee
TI - Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation
T2 - Oncology Research
PY - 2019
VL - 27
IS - 7
SN - 1555-3906
AB - Recently, novel therapeutic strategies have been designed with the aim of killing cancer stem-like cells (CSCs),
and considerable interest has been generated in the development of specific therapies that target stemnessrelated marker of CSCs. In this study, nonsteroidal anti-inflammatory drugs (NSAIDs) significantly potentiated Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG)-mediated cytotoxicity through
apoptotic and autophagic cell death induction, but COX-2-inhibitory function was not required for NSAIDinduced autophagy in CD44-overexpressing human chronic myeloid leukemia K562 (CD44highK562) cells.
Importantly, we found that treatment with NSAIDs resulted in a dose-dependent increase in LC3-II level and
decrease in p62 level and simultaneous reduction in multiple stemness-related markers including CD44, Oct4,
c-Myc, and mutant p53 (mutp53) in CD44highK562 cells, suggesting that NSAIDs could induce autophagy,
which might mediate degradation of stemness-related marker proteins. Activation of AMPK and inhibition
of Akt/mTOR/p70S6K/4EBP1 participated in NSAID-induced autophagy in CD44highK562 cells. In addition,
treatment of CD44highK562 cells with NSAIDs inhibited expression of HSF1/Hsps, which resulted in suppression of 17-AAG-induced activation of Hsp70, leading to reversal of 17-AAG resistance and sensitization of
CD44highK562 cells to 17-AAG by NSAIDs. In conclusion, combining NSAIDs with Hsp90 inhibitor may offer
one of the most promising strategies for eradication of CD44-overexpressing CSCs.
KW - CD44; Hsp90 inhibitor; Nonsteroidal anti-inflammatory drugs (NSAIDs); Stemness-related markers; Autophagy
DO - 10.3727/096504019X15517850319579